Clindamycin Phosphate Injection

• • Cleocin injection, Pfizer, 150 mg/mL, 2 mL ADD-Vantage vial, 25 count, NDC 00009-6582-01
  • Cleocin injection, Pfizer, 150 mg/mL, 2 mL vial, 25 count, NDC 00009-0870-26
  • Cleocin injection, Pfizer, 150 mg/mL, 4 mL ADD-Vantage vial, 25 count, NDC 00009-3124-03
  • Cleocin injection, Pfizer, 150 mg/mL, 4 mL vial, 25 count, NDC 00009-0775-26
  • Cleocin injection, Pfizer, 150 mg/mL, 6 mL ADD-Vantage vial, 25 count, NDC 00009-3447-03
  • Cleocin injection, Pfizer, 150 mg/mL, 6 mL vial, 25 count, NDC 00009-0902-18
  • Clindamycin phosphate injection, Akorn, 300 mg/50 mL, in 5% dextrose premixed bottle, 1 count, NDC 17478-0120-50 - discontinued
  • Clindamycin phosphate injection, Akorn, 600 mg/50 mL, premixed bottle, 1 count, NDC 17478-0121-50 - discontinued
  • Clindamycin phosphate injection, Akorn, 900 mg/50 mL, premixed bottle, 1 count, NDC 17478-0122-50 - discontinued
  • Clindamycin phosphate injection, Almaject, 150 mg/mL, 2 mL ADD-Vantage vial, 25 count, NDC 72611-0762-25 - discontinued
  • Clindamycin phosphate injection, Almaject, 150 mg/mL, 4 mL ADD-Vantage vial, 25 count, NDC 72611-0767-25 - discontinued
  • Clindamycin phosphate injection, Almaject, 150 mg/mL, 6 mL ADD-Vantage vial, 25 count, NDC 72611-0769-25 - discontinued
  • Clindamycin phosphate injection, Baxter, 300 mg/50 mL, in 0.9% sodium chloride premixed container, 24 count, NDC 00338-9545-24
  • Clindamycin phosphate injection, Baxter, 300 mg/50 mL, in 5% dextrose premixed container, 24 count, NDC 00338-3410-24
  • Clindamycin phosphate injection, Baxter, 600 mg/50 mL, in 0.9% sodium chloride premixed container, 24 count, NDC 00338-9549-24
  • Clindamycin phosphate injection, Baxter, 600 mg/50 mL, in 5% dextrose premixed container, 24 count, NDC 00338-3612-24
  • Clindamycin phosphate injection, Baxter, 900 mg/50 mL, in 0.9% sodium chloride premixed container, 24 count, NDC 00338-9553-24
  • Clindamycin phosphate injection, Baxter, 900 mg/50 mL, in 5% dextrose premixed container, 24 count, NDC 00338-3814-24
  • Clindamycin phosphate injection, Sagent, 150 mg/mL, 2 mL vial, 25 count, NDC 25021-0115-02
  • Clindamycin phosphate injection, Sagent, 150 mg/mL, 4 mL vial, 25 count, NDC 25021-0115-04
  • Clindamycin phosphate injection, Sagent, 150 mg/mL, 6 mL vial, 25 count, NDC 25021-0115-06

• • Alvogen injectable generic products including clindamycin are being marketed under the brand, Almaject Inc., as of October 1, 2019. The NDC numbers for these products have changed.
  • Akorn discontinued clindamycin injection in early 2020.
  • Baxter has clindamycin injection on shortage due to manufacturing delays.
  • Fresenius Kabi did not provide a reason for the shortage.
  • Pfizer did not provide a reason for the shortages. Pfizer discontinued Cleocin premixed bags in 2018.
  • Sagent did not provide a reason for the shortage.
  • Sandoz did not provide a reason for the shortage.

• • Cleocin injection, Pfizer, 150 mg/mL, 60 mL bulk vial, 5 count, NDC 00009-0728-09
  • Clindamycin phosphate injection, Almaject, 150 mg/mL, 2 mL vial, 25 count, NDC 72611-0634-25
  • Clindamycin phosphate injection, Almaject, 150 mg/mL, 4 mL vial, 25 count, NDC 72611-0639-25
  • Clindamycin phosphate injection, Almaject, 150 mg/mL, 6 mL vial, 25 count, NDC 72611-0642-25
  • Clindamycin phosphate injection, Almaject, 150 mg/mL, 60 mL bulk vial, 1 count, NDC 72611-0645-55
  • Clindamycin phosphate injection, Fresenius Kabi, 150 mg/mL, 2 mL vial, 25 count, NDC 63323-0282-02
  • Clindamycin phosphate injection, Fresenius Kabi, 150 mg/mL, 4 mL vial, 25 count, NDC 63323-0282-04
  • Clindamycin phosphate injection, Fresenius Kabi, 150 mg/mL, 6 mL vial, 25 count, NDC 63323-0282-06
  • Clindamycin phosphate injection, Fresenius Kabi, 150 mg/mL, 60 mL vial, 1 count, NDC 63323-0282-60
  • Clindamycin phosphate injection, Sagent, 150 mg/mL, 60 mL bulk vial, 1 count, NDC 25021-0115-51
  • Clindamycin phosphate injection, Sandoz, 300 mg/50 mL, in 5% dextrose premixed container, 24 count, NDC 00781-3288-09
  • Clindamycin phosphate injection, Sandoz, 600 mg/50 mL, in 5% dextrose premixed container, 24 count, NDC 00781-3289-09
  • Clindamycin phosphate injection, Sandoz, 900 mg/50 mL, in 5% dextrose premixed container, 24 count, NDC 00781-3290-09

Estimated Resupply Dates

• • Baxter has all clindamycin phosphate injection presentations on back order and the company estimates a release date of mid-May 2020.
  • Pfizer has Cleocin 150 mg/mL 2 mL, 4 mL, and 6 mL ADD-Vantage vials on back order and the company estimates a release date of February 2023. Clindamycin 150 mg/mL 2 mL and 4 mL vials are available in limited supply. The 150 mg/mL 6 mL vials are on back order and the company estimates a release date of May 2020.
  • Sagent has clindamycin phosphate 150 mg/mL 2 mL and 4 mL vials on back order and the company estimates a release date of June 2020. The 6 mL vials are on allocation.